Skip to content

Prevalence of Primary Aldosteronism in Patients With Stroke

Prevalence of Primary Aldosteronism in Patients With Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03789357
Enrollment
300
Registered
2018-12-28
Start date
2018-05-01
Completion date
2021-09-30
Last updated
2022-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Aldosteronism, Stroke

Keywords

Hypertension, Arrhythmia, Adrenal vein sampling, Mineralocorticoid-receptor Antagonists

Brief summary

Strokes leads to significant morbidity and mortality, and hypertension is the most important risk factor for strokes. It is estimated that up to 10% of patients with hypertension have the underlying, treatable condition of primary aldosteronism. Hence, we hypothesize that the prevalence of primary aldosteronism is high in patients with strokes, a complication of long-standing hypertension. Patients admitted with an acute stroke to the Acute Stroke Unit, Changi General Hospital, will be screened for Primary Aldosteronism three months post-stroke, and confirmatory tests will be done with saline-infusion test.

Interventions

DIAGNOSTIC_TESTAldosterone renin ratio

Aldosterone Renin Ratio to screen for Primary Aldosteronism

Sponsors

Changi General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years

Inclusion criteria

1. Age 21-80 years 2. Admitted with acute cerebrovascular accident (CVA) or transient ischemic attack (TIA) to the ASU, CGH 3. Patients with both ischemic and hemorrhagic strokes

Exclusion criteria

a. Pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients with stroke with confirmed primary aldosteronism in patients admitted to the acute stroke unit for stroke6 monthsPercentage of patients with confirmed Primary Aldosteronism using confirmatory test

Secondary

MeasureTime frameDescription
Accuracy of Screening test in early period post-stroke3 monthsTo determine if the screening blood test for primary aldosteronism performed within 1 week post-stroke is equally accurate compared to being performed 2-4 months post-stroke.
Percentage of unilateral primary aldosteronism in patients admitted with acute stroke6 monthsPercentage of unilateral PA amongst patients with stroke
Percentage of patients with positive screening test in patients admitted with acute stroke3 months
Blood pressure change after treatment for primary aldosteronism12 months
Cardiac Complications6 monthsCardiac complications in patients with primary aldosteronism, compared to those without primary aldosteronism, as assessed by transthoracic echocardiography features of left ventricular hypertrophy / mass, and diastolic dysfunction

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026